In the third way, the Walker process, driven by the Ottawa Group, they say they're aiming to tackle issues like supply chains, export restrictions and other issues that the industry has identified as being barriers to production. Unfortunately, it contains nothing on intellectual property, so it's not seen as a viable alternative by the 100-plus countries that identified intellectual property as the biggest obstacle to their ability to secure life-saving tools.
I would say that it muddied the waters at the WTO and that it probably did indeed postpone a consensus on the TRIPS waiver.